KX826( also known as Pyrilutamide ) is an androgen receptor (AR) antagonist and a potential first-in-class topical drug for the treatment of androgenetic alopecia (AGA) and acne vulgaris.

ORM-15341 is a novel, potent and full antagonist of human androgen receptor (hAR) with IC50 values of 38 nM as shown by transactivation assays in AR-HEK293 cells stably expressing full-length hAR and an androgen-responsive luciferase reporter gene construct.

Testolone (formerly known as RAD140) is a novel, potent, orally bioavailable, nonsteroidal selective androgen receptor modulator (SARM) that is being investigated for the treatment of conditions such as muscle wasting and breast cancer.

UT-155 is a potent and selective androgen receptor (AR) degrader (SARD) that markedly reduces the activity of wild-type and splice variant isoforms of AR at submicromolar doses.

D4-abiraterone is an active metabolite of abiraterone Δ4-Abiraterone (D4A) which is a CYP17A1 inhibitor and an androgen receptor antagonist (IC50 of 5.3 nM). Abiraterone (formerly CB-7598; Zytiga) is an approved anticancer medication acting as an irreversible and selective CYP17 inhibitor.

Danazol is a novel and potent analogue of the synthetic steroid ethisterone acting as a testosterone gonadotropin inhibitor with weak androgenic effects.